BMS-813160

Item number	Size	Manual	Delivery time	Price
TGM-T4584-1mg	1 mg	-	7 - 10 business days*	56.00€
TGM-T4584-5mg	5 mg	-	7 - 10 business days*	136.00€
TGM-T4584-1mL	1 ml	-	7 - 10 business days*	145.00€
TGM-T4584-10mg	10 mg	-	7 - 10 business days*	192.00€
TGM-T4584-25mg	25 mg	-	7 - 10 business days*	351.00€
TGM-T4584-50mg	50 mg	-	7 - 10 business days*	585.00€
TGM-T4584-100mg	100 mg	-	7 - 10 business days*	835.00€
TGM-T4584-500mg	500 mg	-	7 - 10 business days*	1,697.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for... more

Close menu

Product information "BMS-813160"

Description: BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular. Target: CCR. Smiles: CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(nn23)C(C)(C)C)C1=O)NC(C)(C)C. References: Norman P. et al. A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916. Expert Opin Ther Pat. 2011 Dec,21(12):1919-24.

Keywords:	BMS 813160
Supplier:	TargetMol
Supplier-Nr:	T4584

Properties

Application:	CCR2/CCR5 dual antagonist
MW:	484.64 D
Formula:	C25H40N8O2

Database Information

CAS :	1286279-29-5\| Matching products
KEGG ID :	K04177 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "BMS-813160"

Write a review